U.S. markets closed
  • S&P 500

    4,431.85
    +105.34 (+2.43%)
     
  • Dow 30

    34,725.47
    +564.69 (+1.65%)
     
  • Nasdaq

    13,770.57
    +417.79 (+3.13%)
     
  • Russell 2000

    1,968.51
    +37.22 (+1.93%)
     
  • Crude Oil

    87.29
    +0.68 (+0.79%)
     
  • Gold

    1,792.30
    -2.70 (-0.15%)
     
  • Silver

    22.49
    -0.19 (-0.82%)
     
  • EUR/USD

    1.1152
    +0.0005 (+0.04%)
     
  • 10-Yr Bond

    1.7820
    -0.0250 (-1.38%)
     
  • GBP/USD

    1.3401
    +0.0019 (+0.14%)
     
  • USD/JPY

    115.1900
    -0.1120 (-0.10%)
     
  • BTC-USD

    37,730.07
    +554.79 (+1.49%)
     
  • CMC Crypto 200

    863.83
    +21.37 (+2.54%)
     
  • FTSE 100

    7,466.07
    -88.24 (-1.17%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

Earnings Outlook For Marrone Bio Innovations

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • MBII

Marrone Bio Innovations (NASDAQ: MBII) announces its next round of earnings this Monday, August 10. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement.

Earnings and Revenue

Wall Street analysts see Marrone Bio Innovations reporting a quarterly EPS of $-0.04 per share on sales of $10.38 million. In the same quarter last year, Marrone Bio Innovations posted EPS of $-0.06 on sales of $7.00 million. If the company were to match the consensus estimate when it reports Monday, earnings would be up 33.33%. Revenue would be up 2.67% from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:

EPS Estimate

-0.03

-0.06

-0.05

-0.04

EPS Actual

-0.05

-0.07

-0.05

-0.06

Revenue Estimate

10.11 M

7.34 M

6.95 M

8.33 M

Revenue Actual

9.65 M

6.70 M

6.97 M

7.00 M

Stock Performance

Over the past 52-week period, shares of Marrone Bio Innovations have declined 4.63%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.

View more earnings on MBII

Don't be surprised to see the stock move on comments made during its conference call. Marrone Bio Innovations is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://viavid.webcasts.com/starthere.jsp?ei=1348996&tp_key=2053189d5f

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.